Literature DB >> 26519208

Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension.

Adeleye J Afolayan1, Annie Eis2, Maxwell Alexander2, Teresa Michalkiewicz2, Ru-Jeng Teng2, Satyan Lakshminrusimha3, Girija G Konduri2.   

Abstract

Impaired vasodilation in persistent pulmonary hypertension of the newborn (PPHN) is characterized by mitochondrial dysfunction. We investigated the hypothesis that a decreased endothelial nitric oxide synthase level leads to impaired mitochondrial biogenesis and function in a lamb model of PPHN induced by prenatal ductus arteriosus constriction. We ventilated PPHN lambs with 100% O2 alone or with inhaled nitric oxide (iNO). We treated pulmonary artery endothelial cells (PAECs) from normal and PPHN lambs with detaNONOate, an NO donor. We observed decreased mitochondrial (mt) DNA copy number, electron transport chain (ETC) complex subunit levels, and ATP levels in PAECs and lung tissue of PPHN fetal lambs at baseline compared with gestation matched controls. Phosphorylation of AMP-activated kinase (AMPK) and levels of peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α) and sirtuin-1, which facilitate mitochondrial biogenesis, were decreased in PPHN. Ventilation with 100% O2 was associated with larger decreases in ETC subunits in the lungs of PPHN lambs compared with unventilated PPHN lambs. iNO administration, which facilitated weaning of FiO2 , partly restored mtDNA copy number, ETC subunit levels, and ATP levels. DetaNONOate increased eNOS phosphorylation and its interaction with heat shock protein 90 (HSP90); increased levels of superoxide dismutase 2 (SOD2) mRNA, protein, and activity; and decreased the mitochondrial superoxide levels in PPHN-PAECs. Knockdown of eNOS decreased ETC protein levels in control PAECs. We conclude that ventilation with 100% O2 amplifies oxidative stress and mitochondrial dysfunction in PPHN, which are partly improved by iNO and weaning of oxygen.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  SOD2; biogenesis; eNOS; mitochondria; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26519208      PMCID: PMC4698434          DOI: 10.1152/ajplung.00392.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  40 in total

1.  Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation.

Authors:  Satyan Lakshminrusimha; James A Russell; Robin H Steinhorn; Rita M Ryan; Sylvia F Gugino; Frederick C Morin; Daniel D Swartz; Vasanth H Kumar
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

2.  Key regulators of mitochondrial biogenesis are increased in kidneys of growth hormone receptor knockout (GHRKO) mice.

Authors:  Adam Gesing; Andrzej Bartke; Feiya Wang; Malgorzata Karbownik-Lewinska; Michal M Masternak
Journal:  Cell Biochem Funct       Date:  2011-07-14       Impact factor: 3.685

Review 3.  Meconium aspiration syndrome: historical aspects.

Authors:  A A Fanaroff
Journal:  J Perinatol       Date:  2008-12       Impact factor: 2.521

Review 4.  Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.

Authors:  P Puigserver
Journal:  Int J Obes (Lond)       Date:  2005-03       Impact factor: 5.095

Review 5.  Developmental expression of vasoactive and growth factors in human lung. Role in pulmonary vascular resistance adaptation at birth.

Authors:  Marilyne Lévy; Christelle Maurey; A Tuan Dinh-Xuan; Pascal Vouhé; Dominique Israël-Biet
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

Review 6.  Mitochondria in vascular health and disease.

Authors:  Peter Dromparis; Evangelos D Michelakis
Journal:  Annu Rev Physiol       Date:  2012-11-16       Impact factor: 19.318

Review 7.  Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.

Authors:  Demosthenes G Papamatheakis; Madalitso Chundu; Arlin B Blood; Sean M Wilson
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

8.  Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. The Franco-Belgium Collaborative NO Trial Group.

Authors: 
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

9.  Sepiapterin improves angiogenesis of pulmonary artery endothelial cells with in utero pulmonary hypertension by recoupling endothelial nitric oxide synthase.

Authors:  Ru-Jeng Teng; Jianhai Du; Hao Xu; Ivane Bakhutashvili; Annie Eis; Yang Shi; Kirkwood A Pritchard; Girija G Konduri
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-27       Impact factor: 5.464

Review 10.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

View more
  29 in total

Review 1.  Therapies that enhance pulmonary vascular NO-signaling in the neonate.

Authors:  Julie Dillard; Marta Perez; Bernadette Chen
Journal:  Nitric Oxide       Date:  2019-12-20       Impact factor: 4.427

Review 2.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

3.  Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.

Authors:  Hagir B Suliman; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

Review 4.  Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant.

Authors:  Gregory M Sokol; Girija G Konduri; Krisa P Van Meurs
Journal:  Semin Perinatol       Date:  2016-10       Impact factor: 3.300

Review 5.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

Review 6.  Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains.

Authors:  Miranda K Culley; Stephen Y Chan
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

7.  Persistent pulmonary hypertension alters the epigenetic characteristics of endothelial nitric oxide synthase gene in pulmonary artery endothelial cells in a fetal lamb model.

Authors:  Xingrao Ke; Hollis Johnson; Xigang Jing; Teresa Michalkiewicz; Yi-Wen Huang; Robert H Lane; Girija G Konduri
Journal:  Physiol Genomics       Date:  2018-07-13       Impact factor: 3.107

8.  Weaning disrupts intestinal antioxidant status, impairs intestinal barrier and mitochondrial function, and triggers mitophagy in piglets.

Authors:  S T Cao; C C Wang; H Wu; Q H Zhang; L F Jiao; C H Hu
Journal:  J Anim Sci       Date:  2018-04-03       Impact factor: 3.159

9.  AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension.

Authors:  Ujala Rana; Emily Callan; Brianna Entringer; Teresa Michalkiewicz; Amit Joshi; Abdul K Parchur; Ru-Jeng Teng; Girija G Konduri
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

Review 10.  Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.

Authors:  S Lakshminrusimha; G G Konduri; R H Steinhorn
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.